Observational Study Investigating the Response Rate of Itraconazole Injection in Treating Immunocompromised Patients

NCT01060462 · clinicaltrials.gov ↗

COMPLETED

Status

438

Enrollment

INDUSTRY

Sponsor class

Conditions

Hematological Malignancies
Neutropenia
Fever

Interventions

DRUG: Pts. w/ neutropenic fever associated w/ hematologic malignancy

Sponsor

Janssen Korea, Ltd., Korea